Ceapro (CZO) Stock Price, News & Analysis

Company Overview

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

Key Stats

• Today's Range: C$0.23 to C$0.24
• 50-Day Range: C$0.23 to C$0.23
• 52-Week Range: C$0.15 to C$0.54
• Volume: 5,850 shs
• Average Volume: 50,562 shs
• Market Capitalization: C$688,880.00
• P/E Ratio: N/A
• Dividend Yield: 1.80%
• Price Target: N/A
• Consensus Rating: N/A

CZO Stock Analysis - Frequently Asked Questions

How have CZO shares performed this year?

Ceapro's stock was trading at C$0.23 at the beginning of 2025. Since then, CZO shares have increased by 0.0% and is now trading at C$0.23.
View the best growth stocks for 2025 here.

How do I buy shares of Ceapro?

Shares of CZO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Ceapro own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ceapro investors own include Franco-Nevada (FNV), Facedrive (FDVRF), FLYHT Aerospace Solutions (FLY), Ackroo (AKR), Badger Daylighting (BAD), BeWhere (BEW) and BlueRush (BTV).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:CZO
• CIK: N/A
• Web: www.ceapro.com
• Phone: +1-780-4214555
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 5.63
• P/E Growth: N/A
• Net Income: C$-243,041.50
• Net Margins: -69.73%
• Pretax Margin: N/A
• Return on Equity: -21.67%
• Return on Assets: -11.30%

Debt

• Debt-to-Equity Ratio: 8.28
• Current Ratio: 7.10
• Quick Ratio: 18.88

Sales & Book Value

• Annual Sales: C$348,522.40
• Price / Sales: 1.98
• Cash Flow: C$0.06 per share
• Price / Cash Flow: 3.94
• Book Value: C$0.33 per share
• Price / Book: 0.68

Miscellaneous

• Outstanding Shares: 3,061,689
• Free Float: N/A
• Market Cap: C$688,880.00
• Optionable: Not Optionable
• Beta: 1.38